Search results
On an Immunotherapy Drug? Acetaminophen Makes It Less Effective, Research Says
Woman's World via Yahoo News· 1 year agoIf you or a loved one has cancer, you know by now that anti-cancer drugs are hard on the body. They...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Looking to the future Cancer specialists optimistic about expanded melanoma treatments
The Ledger via Yahoo News· 2 years agoThe past decade was an exciting time for patients diagnosed with advanced melanoma, the least common...
2 Biotechs That Could Get Bought Out in 2024
Motley Fool via Yahoo Finance· 4 months agoBig pharma is facing another round of major patent expirations. Before the decade's end, Bristol Myers Squibb (BMS) will lose exclusivity for the...
Novocure Crashes 43% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment
Investor's Business Daily· 11 months agoA medical device from Novocure extended overall survival for lung cancer patients, but NVCR stock...
IBD Stock Of The Day: Bristol Myers Eyes Breakout After $4.1 Billion Buyout
Investor's Business Daily· 2 years agoBristol Myers Squibb is the IBD Stock Of The Day as BMY stock bounds off its 50-day line, presenting...
A Patent Cliff Is Coming For Bristol Myers — Can Billions In New Products Fill The Gap?
Investor's Business Daily· 1 year agoIt's a new day at Bristol Myers Squibb, according to a company executive. But BMY stock remains...
Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal
Reuters via Yahoo News· 2 years ago(Reuters) -Bristol Myers Squibb Co said on Friday it will acquire drug developer Turning Point...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
Motley Fool· 1 year agoShares in pharmaceutical company Bristol Myers Squibb (NYSE: BMY) are up a little more than 11% over...
